Pharmacokinetics of a new tetramethylpyrazine analogue CXC195 in rats

Drug Research

Volumn 63, Issue 7, 2013, Pages 342-345

  Wei, C ^a,b   Kong, L ^a   Wei, X ^a   Chen, L ^a   Liu, X ^a,a   Zhang, X ^a   Liu, H ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

CXC195; HPLC; pharmacokinetics; tetramethylpyrazine

Indexed keywords

CXC 195; NEUROPROTECTIVE AGENT; TETRAMETHYLPYRAZINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PHARMACOKINETICS; PLASMA CONCENTRATION-TIME CURVE; RAT; ULTRAVIOLET DETECTOR;

EID: 84881229016     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0033-1341423     Document Type: Article

References (6)

1. Jia J., Zhang X., Hu Y. S. et al. Protective effect of tetraethyl pyrazine against focal cerebral ischemia/reperfusion injury in rats: therapeutic time window and its mechanism. Thromb Res: 2009; 123 727 730
2. Kao T. K., Ou Y. C., Kuo J. S. et al. Neuroprotection by tetramethylpyrazine against ischemic brain injury in rats. Neurochem Int: 2006; 48 166 176
3. Liao S. L., Kao T. K., Chen W. Y. et al. Tetramethylpyrazine reduces ischemic brain injury in rats. Neurosci Lett: 2004; 372 40 45
4. Cheng X. C., Liu X. Y., Xu W. F. et al. Design, synthesis, and biological activities of novel Ligustrazine derivatives. Bioorg Med Chem: 2007; 15 3315 3320
5. Ou Y., Dong X., Liu X. Y. et al. Mechanism of tetramethylpyrazine analogue CXC195 inhibition of hydrogen peroxide-induced apoptosis in human endothelial cells. Biol Pharm Bull: 2010; 33 432 438
6. Guidance for Industry: Bioanalytical Method Validation US Department of Health and Human Services, FDA, CDER and CVM. 2001